We are live on ! Find out more
CC

Callan Capital Portfolio holdings

AUM $1.35B
1-Year Est. Return 8.35%
This Fund
S&P 500
This Quarter Est. Return
+6.24%
1 Year Est. Return
+8.35%
3 Year Est. Return
+20.11%
5 Year Est. Return
+98.58%
10 Year Est. Return
+95.87%
AUM
$688M
AUM Growth
+$86.5M
Cap. Flow
+$50.5M
Cap. Flow %
7.33%
Top 10 Hldgs %
64.99%
Holding
134
New
47
Increased
52
Reduced
18
Closed
1

Sector Composition

Rank Sector Weight
1 Miscellaneous 93.45%
2 Technology 3.27%
3 Consumer Discretionary 0.87%
4 Communication Services 0.83%
5 Financials 0.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZTS icon
126
Zoetis
ZTS
$32B
$230K 0.03%
+943
New +$207K
MKC icon
127
McCormick & Company Non-Voting
MKC
$14.9B
$218K 0.03%
+2,256
New +$192K
PANW icon
128
Palo Alto Networks
PANW
$303B
$214K 0.03%
+2,310
New +$200K
DHR icon
129
Danaher
DHR
$152B
$202K 0.03%
+690
New +$190K
PM icon
130
Philip Morris
PM
$299B
$202K 0.03%
2,126
MPC icon
131
Marathon Petroleum
MPC
$104B
$201K 0.03%
+3,140
New +$202K
NAD icon
132
Nuveen Quality Municipal Income Fund
NAD
$2.73B
$161K 0.02%
+10,000
New +$157K
EVFM
133
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
-3,333
Closed -$37K

Similar funds

Callan Capital's Q4 2021 Portfolio in Review

As of Q4 2021, Callan Capital held 134 positions worth $688M, up 14% from $602M the previous quarter. Its ten largest holdings account for 65% of the portfolio.

Callan Capital deployed $50.5M of net new capital in Q4 2021, opening 47 new positions and adding to 52 existing holdings. Its largest new stake was State Street SPDR Portfolio Developed World ex-US ETF: 37,340 shares worth $1.36M.

By sector, the portfolio is most concentrated in Miscellaneous at 93% of assets, down from 95% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was JPMorgan Ultra-Short Income ETF, an estimated $859K trimmed.

  • Callan Capital's largest Q4 2021 buy was State Street SPDR Portfolio Developed World ex-US ETF: 37,340 shares worth $1.36M.
  • Callan Capital added most to Schwab International Equity ETF in Q4 2021, an estimated $5.67M increase.
  • Callan Capital's biggest Q4 2021 reduction was JPMorgan Ultra-Short Income ETF, cutting an estimated $859K.
  • Callan Capital fully exited Evofem Biosciences, Inc. Common Stock in Q4 2021, selling an estimated $37K.
  • Callan Capital's ten largest holdings make up 65% of its $688M portfolio in Q4 2021.
  • Callan Capital opened 47 new positions and closed 1 in Q4 2021.
  • Callan Capital's portfolio value rose 14% quarter-over-quarter to $688M.

Based on Callan Capital's 13F filing for Q4 2021, filed 21 Jan 2022.